ReNu Lawsuit & News Blog
ReNu Lawsuits and Class Actions | ReNu Eye Infection Blog Home | ReNu Archives | ReNu Articles | ReNu Eye Infections Category Index |

Do I have a ReNu Lawsuit?
ReNu Lawsuits and Class Actions : ReNu Eye Infection Blog Home : Litigation Impact on Bausch & Lomb : Article

Support for Bausch & Lomb stock even while Fungal eye infection spans US

Bausch & Lomb stock rose considerably after a report in the Journal of American Medicine said that fulsarium keratitis was caused by poor eye hygiene. Upon further inspection the report was using a sampling from contact lens wearers in Singapore. Following the report, shares of B&L rose from $2.40 to $49.81. But U.S. public health agencies, such as the Food and Drug Administration and the Centers for Disease Control and Prevention, are still investigating the infection outbreak in the United States and have yet to arrive at the same conclusion.

At least 30 states and Puerto Rico have had reports of the fungal eye infection fulsarium keratatis. Typically, one case of fulsarium keratatis is about average but ophthalmologists are seeing double digit cases since Bausch & Lomb's ReNu with MoistureLoc was recalled in May 2006. So far at least one confirmed or possible case has appeared in the following states: AR, AZ, CA, CT, FL, GA, IA, IL, KS, KY, LA, MA, MD, MI, MO, NC, ND, NJ, NY, OH, OK, PA, TN, TX, and VT plus Puerto Rico. States where all cases under investigation include: IN, MN, MS, NV, OR, and RI.